Anisole

Anisole

SCHEMBL640408

COc1ccccc1.O=S(=O)(O)Cl

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.64
LTA4H P09960 1/20 0.54
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
PKM P14618 2/20 0.46
PGR P06401 2/20 0.46
HSD11B1 P28845 1/20 0.46
HTT P42858 2/20 0.46
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
PPARG P37231 1/20 0.44
NFE2L2 Q16236 1/20 0.44
ACP3 P15309 1/20 0.44
BACE1 P56817 1/20 0.44
GAA P10253 2/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anisole SCHEMBL415394 0.91 CA4 (0.70) CA4LTA4HCES2CES1PKM
Anisole SCHEMBL1873043 0.91 CA4 (0.70) CA4LTA4HCES2CES1PKM
Anisole SCHEMBL25392752 0.88 CA4 (0.67) CA4LTA4HCES2CES1PKM
Anisole SCHEMBL29973795 0.88 CA4 (0.67) CA4LTA4HCES2CES1PKM
Anisole SCHEMBL7165189 0.88 CA4 (0.67) CA4LTA4HCES2CES1PKM
Anisole SCHEMBL9269922 0.88 CA4 (0.67) CA4LTA4HCES2CES1PKM
1,4-Dimethoxybenzene SCHEMBL3855313 0.88 PKM (0.58) CES2CES1PKMCA1CA2
Anisole SCHEMBL10674071 0.87 CA4 (0.58) CA4LTA4HCES2CES1PKM
Anisole SCHEMBL6771858 0.86 CA4 (0.64) CA4LTA4HCES2CES1PKM
Anisole SCHEMBL27905059 0.86 CA4 (0.64) CA4LTA4HCES2CES1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119805-B2 Substituted disulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US disclosed
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed
EP-0221344-B1 SULPHONYL-PHENYL ALKYL AMINES, PROCESS FOR THEIR PREPARATION AND MEDICINES Roche Diagnostics GmbH (DE) 1990-05-23 EP disclosed
EP-0221344-A1 Sulphonyl-phenyl alkyl amines, process for their preparation and medicines Roche Diagnostics GmbH (DE) 1987-05-13 EP disclosed
EP-0093363-B1 PROCESS FOR THE PREPARATION OF DISULPHIDES CASSELLA Aktiengesellschaft (DE) 1987-01-14 EP disclosed
EP-0059241-B1 PROCESS FOR PREPARING AROMATIC SULFONYL HALOGENIDES BASF Aktiengesellschaft (DE) 1986-01-29 EP disclosed
US-4464537-A Preparation of saccharin BASF AKTIENGESELLSCHAFT (DE) 1984-08-07 US disclosed
EP-0052750-B1 PROCESS FOR THE PREPARATION OF SACCHARIN BASF Aktiengesellschaft (DE) 1984-03-28 EP disclosed
EP-0031954-B1 SULPHONAMIDES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS Roche Diagnostics GmbH (DE) 1984-03-14 EP disclosed
EP-0093363-A1 Process for the preparation of disulphides CASSELLA Aktiengesellschaft (DE) 1983-11-09 EP disclosed
EP-0059241-A1 Process for preparing aromatic sulfonyl halogenides BASF Aktiengesellschaft (DE) 1982-09-08 EP disclosed
EP-0052750-A1 Process for the preparation of saccharin BASF Aktiengesellschaft (DE) 1982-06-02 EP disclosed
EP-0031954-A2 Sulphonamides, process for their preparation and medicines containing these compounds Roche Diagnostics GmbH (DE) 1981-07-15 EP disclosed
EP-0002680-B1 4-SPECTINOMYCYLAMIN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS, METHOD OF PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE SUBSTANCES Dr. Karl Thomae GmbH (DE) 1981-02-11 EP disclosed
EP-0002680-A2 4-Spectinomycylamin and its physiologically acceptable salts, method of preparation and pharmaceutical products containing these substances Dr. Karl Thomae GmbH (DE) 1979-07-11 EP disclosed
US-4039511-A Process for the manufacture of polyethers from bisphenates and sulfonyl halides BASF AKTIENGESELLSCHAFT (DT) 1977-08-02 US disclosed
US-3932419-A QUINOLINE DYES BAYER AKTIENGESELLSCHAFT (DT) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152158-A1 Substituted Disulfonamide Compounds BDKRB1, BDKRB2, BRS3 CA4 2472/4885LTA4H 1220/4885CES2 1954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.